DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Simpson EL, Gadkari A, Worm M. , et al.
Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): A phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD).
J Am Acad Dermatol 2016;
75 (03) 506-515
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.